Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma

The mechanisms underlying the resistance to immune checkpoint inhibitors (ICIs) therapy in metastatic urothelial carcinoma (mUC) patients are not clear. It is of great significance to discern mUC patients who could benefit from ICI therapy in clinical practice. In this study, we performed machine le...

Full description

Bibliographic Details
Main Authors: Siteng Chen, Ning Zhang, Tao Wang, Encheng Zhang, Xiang Wang, Junhua Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.01900/full